Discovery of a Novel Chemical Scaffold for Dual MDM2 and MDM4 Inhibition
Abstract p53 is frequently inactivated through overexpression of MDM2 and MDM4, highlighting the need for effective MDM2/MDM4 dual inhibitors. In this work, an MDM2/MDM4-based virtual screening led to the identification of etrasimod as dual MDM2/MDM4 inhibitor. Guided by structural insights, rational modification of the cyclopentyl substituent afforded a series of six cyclopenta[b]indole derivatives designed to improve interactions in the hydrophobic Leu-26 pocket in both proteins. This optimization resulted in enhanced dual inhibitory activity, with the most potent analogue bearing a 3,4-dichlorophenyl substituent exhibiting IC50 values of 1.6 μM (MDM2) and 2.6 μM (MDM4) in binding assays. Moreover, mechanistic studies in SJSA-1 cells demonstrated a significant increase in p53 steady-state protein levels, as well as cleaved caspase-3 and cleaved PARP, consistent with p53 pathway engagement and activation of apoptosis. Overall, this study identifies cyclopenta[b]indoles as a new chemical scaffold for dual MDM2/MDM4 inhibition providing a basis for further biochemical and cellular optimization.
Authors
- Elizabeth A. Lopes (ORCID: https://orcid.org/0000-0001-5746-4058)
- Maria M. M. Santos (ORCID: https://orcid.org/0000-0002-2239-9353)
- Ricardo J. Ferreira (ORCID: https://orcid.org/0000-0003-2590-8229)
- Shaomeng Wang (ORCID: https://orcid.org/0000-0002-8782-6950)
- Joana D. Amaral (ORCID: https://orcid.org/0000-0001-9504-5102)
- Saad Shaaban (ORCID: https://orcid.org/0000-0002-2578-6260)
- Nuno Maulide (ORCID: https://orcid.org/0000-0003-3643-0718)
- Daniel J. V. A. dos Santos (ORCID: https://orcid.org/0000-0001-7798-8641)
- Cecília M. P. Rodrigues (ORCID: https://orcid.org/0000-0002-4829-754X)
- Mi Wang
Institutions
- University of Vienna (AT)
- University of Lisbon (PT)
- University of Michigan (US)
- Universidade Lusófona (PT)
Publication Details
- Journal
- ACS Medicinal Chemistry Letters
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1021/acsmedchemlett.6c00418
- Primary Topic
- Cancer-related Molecular Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fundação para a Ciência e a Tecnologia
- Rede Nacional de Espectrometria de Massa